» Articles » PMID: 19185646

Contrast-enhanced Magnetic Resonance Imaging Identifies Focal Regions of Intramyocardial Fibrosis in Patients with Severe Aortic Valve Disease: Correlation with Quantitative Histopathology

Abstract

Background: Chronic aortic valve disease (AVD) is characterized by progressive accumulation of interstitial myocardial fibrosis (MF). However, assessment of MF accumulation has only been possible through histologic analyses of endomyocardial biopsies. We sought to evaluate contrast-enhanced magnetic resonance imaging (ce-MRI) as a noninvasive method to identify the presence of increased MF in patients with severe AVD.

Methods: Seventy patients scheduled to undergo aortic valve replacement surgery were examined by cine and ce-MRI in a 1.5-T scanner. Cine images were used for the assessment of left ventricular (LV) volumes, mass, and function. Delayed-enhancement images were used to characterize the regions of MF. In addition, histologic analyses of myocardial samples obtained during aortic valve replacement surgery were used for direct quantification of interstitial MF. Ten additional subjects who died of noncardiac causes served as controls for the quantitative histologic analyses.

Results: Interstitial MF determined by histopathologic analysis was higher in patients with AVD than in controls (2.7% +/- 2.0% vs 0.6% +/- 0.2%, P = .001). When compared with histopathologic results, ce-MRI demonstrated a sensitivity of 74%, a specificity of 81%, and an accuracy of 76% to identify AVD patients with increased interstitial MF. There was a significant inverse correlation between interstitial MF and LV ejection fraction (r = -0.67, P < .0001). Accordingly, patients with identifiable focal regions of MF by ce-MRI exhibited worse LV systolic function than those without MF (45% +/- 14% vs 65% +/- 14%, P < .0001).

Conclusions: Contrast-enhanced MRI allows for the noninvasive detection of focal regions of MF in patients with severe AVD. Moreover, patients with identifiable MF by ce-MRI exhibited worse LV functional parameters.

Citing Articles

Diagnostic value of LGE and T1 mapping in multiple myeloma patients'heart.

Cui Q, Yu J, Ge X, Gao G, Liu Y, He Q BMC Cardiovasc Disord. 2024; 24(1):230.

PMID: 38678215 PMC: 11055279. DOI: 10.1186/s12872-024-03895-y.


Is myocardial fibrosis appropriately assessed by calibrated and 2D strain derived integrated backscatter?.

Lima M, Abecasis J, Reis Santos R, Maltes S, Lopes P, Ferreira A Cardiovasc Ultrasound. 2023; 21(1):14.

PMID: 37568167 PMC: 10422833. DOI: 10.1186/s12947-023-00311-x.


Postoperative myocardial fibrosis assessment in aortic valvular heart diseases-a cardiovascular magnetic resonance study.

Pires L, Rosa V, Morais T, Bello J, Fernandes J, De Santis A Eur Heart J Cardiovasc Imaging. 2023; 24(7):851-862.

PMID: 36935401 PMC: 10284053. DOI: 10.1093/ehjci/jead041.


Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?.

Sweeney M, Corden B, Cook S EMBO Mol Med. 2020; 12(10):e10865.

PMID: 32955172 PMC: 7539225. DOI: 10.15252/emmm.201910865.


Role of Cardiac Computed Tomography in the Diagnosis of Left Ventricular Myocardial Diseases.

Ko S, Hwang S, Lee H J Cardiovasc Imaging. 2019; 27(2):73-92.

PMID: 30993942 PMC: 6470070. DOI: 10.4250/jcvi.2019.27.e17.